BOLD vs PODD · P/E 0.1, $24.6M cap vs P/E 34, rev $2.07B
Boundless Bio, Inc. Common Stock (BOLD) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
BOLD does not have a complete income-statement cache yet.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the BOLD and PODD stock pages for the full models.
Not investment advice.